Skip to main content
Top
Published in: Clinical & Experimental Metastasis 1/2005

01-03-2005

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

Authors: Neslihan Cabioglu, Aysegul Sahin, Michele Doucet, Ekrem Yavuz, Abdullah Igci, Engin O.Yildirim, Esin Aktas, Sema Bilgic, Bayram Kiran, Gunnur Deniz, Janet E. Price

Published in: Clinical & Experimental Metastasis | Issue 1/2005

Login to get access
Metadata
Title
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow
Authors
Neslihan Cabioglu
Aysegul Sahin
Michele Doucet
Ekrem Yavuz
Abdullah Igci
Engin O.Yildirim
Esin Aktas
Sema Bilgic
Bayram Kiran
Gunnur Deniz
Janet E. Price
Publication date
01-03-2005
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 1/2005
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-005-3222-y

Other articles of this Issue 1/2005

Clinical & Experimental Metastasis 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine